This first article in a three-part series sets the scene for healthcare trends in Latin America and covers the impact of currency devaluations, corruption and public-private partnerships (PPPs)
Leela Barham takes a look behind the schemes for patient access in England and puts the case for a review to bring them up to date, in the light of changes since they began in 2009.
Brand success requires pharma companies to identify and meet the needs of all those involved and communicate where the clinical and economic values lie.